Literature DB >> 12088748

Expression of macrophage colony-stimulating factor and its receptor in microglia activation is linked to teratogen-induced neuronal damage.

A-J Hao1, S T Dheen, E-A Ling.   

Abstract

Prenatal exposure to teratogen agents is linked to the pathogenesis of neurodevelopment disorders, but the mechanisms leading to the neurodevelopmental disturbance are poorly understood. To elucidate this, an in vitro model of microglial activation induced by neuronal injury has been characterized. In this connection, exposure of primary microglial cells to the conditioned medium from the neuronal damage induced by teratogen, cyclophosphamide, is accompanied by a reactive microgliosis as assessed by reverse transcription-polymerase chain reaction, enzyme-linked immunosorbent assay, lectin histochemistry, double labeling immunohistochemistry and in situ hybridization. Our results showed that reactive microglia were capable of releasing various cytokines such as tumor necrosis factor-alpha, interleukin-1, interleukin-6, transforming growth factor-beta and nitric oxide. Also, we have shown that macrophage colony-stimulating factor (M-CSF) was in fact produced by the reactive microglia. Concomitant to this was the increased expression of M-CSF receptor in these cells following the teratogen-induced neuronal injury. The up-regulation of M-CSF receptor suggests that the cells are capable of responding to self-derived M-CSF in an autocrine fashion. Results with antibody neutralization further suggest that microglial proinflammatory response, as manifested by cytokine expression in culture, is mediated by M-CSF, which acts as a molecular signal that initiates a microglial reaction. We therefore suggest that microglial activation following cyclophosphamide treatment is not only a response to the neuronal damage, but is also a cause of the damage during pathogenesis of neurodevelopment disorders. To this end, the increased expression of M-CSF and its receptor on microglia would be directly linked to the active cell proliferation and proinflammatory response in the teratogen-induced injury.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12088748     DOI: 10.1016/s0306-4522(02)00144-6

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  9 in total

Review 1.  Roles of activated microglia in hypoxia induced neuroinflammation in the developing brain and the retina.

Authors:  Charanjit Kaur; Gurugirijha Rathnasamy; Eng-Ang Ling
Journal:  J Neuroimmune Pharmacol       Date:  2012-02-26       Impact factor: 4.147

2.  Sleeping beauty-mediated somatic mutagenesis implicates CSF1 in the formation of high-grade astrocytomas.

Authors:  Aaron M Bender; Lara S Collier; Fausto J Rodriguez; Christina Tieu; Jon D Larson; Chandralekha Halder; Eric Mahlum; Thomas M Kollmeyer; Keiko Akagi; Gobinda Sarkar; David A Largaespada; Robert B Jenkins
Journal:  Cancer Res       Date:  2010-04-13       Impact factor: 12.701

Review 3.  CNS inflammation and macrophage/microglial biology associated with HIV-1 infection.

Authors:  Anjana Yadav; Ronald G Collman
Journal:  J Neuroimmune Pharmacol       Date:  2009-09-19       Impact factor: 4.147

4.  Contribution of diffusion-weighted imaging in the evaluation of diffuse white matter ischemic lesions in fetuses: correlations with fetopathologic findings.

Authors:  F Guimiot; C Garel; C Fallet-Bianco; F Menez; S Khung-Savatovsky; J-F Oury; G Sebag; A-L Delezoide
Journal:  AJNR Am J Neuroradiol       Date:  2007-10-18       Impact factor: 3.825

5.  Therapeutic IDOL Reduction Ameliorates Amyloidosis and Improves Cognitive Function in APP/PS1 Mice.

Authors:  Jie Gao; Russell Littman; Graciel Diamante; Xu Xiao; In Sook Ahn; Xia Yang; Tracy A Cole; Peter Tontonoz
Journal:  Mol Cell Biol       Date:  2020-03-30       Impact factor: 4.272

6.  Differential ex vivo nitric oxide production by acutely isolated neonatal and adult microglia.

Authors:  John B Schell; Courtney A Crane; Michael F Smith; Margo R Roberts
Journal:  J Neuroimmunol       Date:  2007-08-15       Impact factor: 3.478

Review 7.  Neuroinflammation and neuroimmune dysregulation after acute hypoxic-ischemic injury of developing brain.

Authors:  Utpal S Bhalala; Raymond C Koehler; Sujatha Kannan
Journal:  Front Pediatr       Date:  2015-01-14       Impact factor: 3.418

Review 8.  Cytokine and Growth Factor Activation In Vivo and In Vitro after Spinal Cord Injury.

Authors:  Elisa Garcia; Jorge Aguilar-Cevallos; Raul Silva-Garcia; Antonio Ibarra
Journal:  Mediators Inflamm       Date:  2016-06-23       Impact factor: 4.711

9.  Cytokine and chemokine alterations in tissue, CSF, and plasma in early presymptomatic phase of experimental allergic encephalomyelitis (EAE), in a rat model of multiple sclerosis.

Authors:  Nozha Borjini; Mercedes Fernández; Luciana Giardino; Laura Calzà
Journal:  J Neuroinflammation       Date:  2016-11-15       Impact factor: 8.322

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.